SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ: SQNM) today announced that President and Chief Executive Officer Harry Stylli, Ph.D., is scheduled to present at the Leerink Swann Roundtable Conference entitled Bugs and Drugs: The Future of Molecular Diagnostics. The conference is being held at the Sofitel New York, in New York City on Thursday, April 3 at 2:20 p.m. Eastern time (11:20 a.m. Pacific time).
